229 related articles for article (PubMed ID: 25081705)
21. Follow-up of Women With Negative Pap Test Results and Abnormal Clinical Signs or Symptoms.
Ocque R; Austin RM
Am J Clin Pathol; 2016 Apr; 145(4):560-7. PubMed ID: 27124948
[TBL] [Abstract][Full Text] [Related]
22. Reasons for improper simple hysterectomy in patients with invasive cervical cancer in the northern region of Thailand.
Srisomboon J; Pantusart A; Phongnarisorn C; Suprasert P
J Obstet Gynaecol Res; 2000 Jun; 26(3):175-80. PubMed ID: 10932978
[TBL] [Abstract][Full Text] [Related]
23. The Value of Papanicolaou Tests in the Diagnosis of Endometrial Carcinoma: A Large Study Cohort From an Academic Medical Center.
Serdy K; Yildiz-Aktas I; Li Z; Zhao C
Am J Clin Pathol; 2016 Mar; 145(3):350-4. PubMed ID: 27124917
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of benign endometrial cells in postmenopausal women.
Ashfaq R; Sharma S; Dulley T; Saboorian MH; Siddiqui MT; Warner C
Diagn Cytopathol; 2001 Oct; 25(4):235-8. PubMed ID: 11599107
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
Kinde I; Bettegowda C; Wang Y; Wu J; Agrawal N; Shih IeM; Kurman R; Dao F; Levine DA; Giuntoli R; Roden R; Eshleman JR; Carvalho JP; Marie SK; Papadopoulos N; Kinzler KW; Vogelstein B; Diaz LA
Sci Transl Med; 2013 Jan; 5(167):167ra4. PubMed ID: 23303603
[TBL] [Abstract][Full Text] [Related]
26. Atypical Findings on Cervicovaginal Smears Correlate with Cervical Involvement by Malignant Mixed Müllerian Tumors of the Uterus.
Hanley KZ; Oprea-Ilies G; Ormenisan C; Seydafkan S; Mosunjac MB
Acta Cytol; 2015; 59(4):319-24. PubMed ID: 26315658
[TBL] [Abstract][Full Text] [Related]
27. Atypical glandular cells of undetermined significance favor endometrial origin. Criteria for separating low grade endometrial adenocarcinoma from benign endometrial lesions.
Salomão DR; Hughes JH; Raab SS
Acta Cytol; 2002; 46(3):458-64. PubMed ID: 12040637
[TBL] [Abstract][Full Text] [Related]
28. Unexpected Significant Uterine Pathological Findings at Vaginal Hysterectomy Despite Unremarkable Preoperative Workup.
Mizrachi Y; Tannus S; Bar J; Sagiv R; Levy T; Condrea A; Ginath S
Isr Med Assoc J; 2017 Oct; 19(10):631-634. PubMed ID: 29103241
[TBL] [Abstract][Full Text] [Related]
29. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
[TBL] [Abstract][Full Text] [Related]
30. Age cutoff for reporting of benign-appearing endometrial cells in Papanicolaou specimens; should it be raised? A 10-year retrospective study from a large county hospital.
Hinson S; Molberg K; Mir M; Flores M; Zheng W; Lucas E
J Am Soc Cytopathol; 2019; 8(2):78-83. PubMed ID: 31287423
[TBL] [Abstract][Full Text] [Related]
31. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
Rooker D; Baalbergen A; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
[TBL] [Abstract][Full Text] [Related]
32. A decade has passed...the Pap smear and cervical cancer.
Linder J
Am J Clin Pathol; 1997 Nov; 108(5):492-8. PubMed ID: 9353086
[No Abstract] [Full Text] [Related]
33. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
34. Small cells in cervical-vaginal smears of patients treated with tamoxifen.
Opjorden SL; Caudill JL; Humphrey SK; Salomão DR
Cancer; 2001 Feb; 93(1):23-8. PubMed ID: 11241262
[TBL] [Abstract][Full Text] [Related]
35. Reasons for inappropriate simple hysterectomy in the presence of invasive cancer of the cervix.
Roman LD; Morris M; Eifel PJ; Burke TW; Gershenson DM; Wharton JT
Obstet Gynecol; 1992 Apr; 79(4):485-9. PubMed ID: 1553163
[TBL] [Abstract][Full Text] [Related]
36. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
Eltabbakh GH; Eltabbakh GD
J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
[TBL] [Abstract][Full Text] [Related]
37. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
38. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women.
Chang A; Sandweiss L; Bose S
Gynecol Oncol; 2001 Jan; 80(1):37-43. PubMed ID: 11136567
[TBL] [Abstract][Full Text] [Related]
39. [Status of fractionated abrasion and vaginal endocervical cytology in diagnosis of endometrial cancer].
Schild R; Kutta T
Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):467-70. PubMed ID: 1397942
[TBL] [Abstract][Full Text] [Related]
40. Lack of transformation zone in cervical Pap tests, should it be a concern? A quality assurance initiative.
Polanco Jacome EC; Maerki J; Chau K; Akerman M; Sajjan S; Klein M; Gimenez C; Laser A; Das K
Diagn Cytopathol; 2018 Jul; 46(7):584-588. PubMed ID: 29722175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
